Abrams Bison Investments LLC Has $91.06 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Abrams Bison Investments LLC trimmed its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 3.2% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 180,000 shares of the healthcare conglomerate's stock after selling 6,000 shares during the period. UnitedHealth Group comprises 9.4% of Abrams Bison Investments LLC's investment portfolio, making the stock its 6th biggest holding. Abrams Bison Investments LLC's holdings in UnitedHealth Group were worth $91,055,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently made changes to their positions in the stock. Tri Locum Partners LP acquired a new stake in UnitedHealth Group in the fourth quarter valued at approximately $14,222,000. Gerber Kawasaki Wealth & Investment Management grew its stake in shares of UnitedHealth Group by 2.3% during the fourth quarter. Gerber Kawasaki Wealth & Investment Management now owns 1,176 shares of the healthcare conglomerate's stock worth $595,000 after purchasing an additional 26 shares in the last quarter. Prosperity Consulting Group LLC raised its stake in UnitedHealth Group by 0.4% in the fourth quarter. Prosperity Consulting Group LLC now owns 12,535 shares of the healthcare conglomerate's stock valued at $6,341,000 after buying an additional 46 shares in the last quarter. Aquatic Capital Management LLC acquired a new position in UnitedHealth Group in the fourth quarter valued at approximately $38,214,000. Finally, Oxford Asset Management LLP purchased a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $286,000. Hedge funds and other institutional investors own 87.86% of the company's stock.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of research reports. Barclays reduced their price target on shares of UnitedHealth Group from $642.00 to $560.00 and set an "overweight" rating for the company in a research report on Monday, April 21st. Oppenheimer reduced their target price on shares of UnitedHealth Group from $640.00 to $600.00 and set an "outperform" rating for the company in a research note on Monday, April 21st. Wells Fargo & Company decreased their price target on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating on the stock in a research note on Tuesday, January 28th. Piper Sandler decreased their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a report on Thursday, January 2nd. Finally, Hsbc Global Res downgraded shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 22nd. Three research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and three have assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and an average price target of $596.86.

UnitedHealth Group Trading Down 0.6 %

UNH stock traded down $2.25 during trading on Friday, reaching $398.44. 7,547,223 shares of the stock traded hands, compared to its average volume of 4,583,871. UnitedHealth Group Incorporated has a 52-week low of $393.31 and a 52-week high of $630.73. The business's 50 day moving average price is $497.29 and its 200-day moving average price is $529.82. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The firm has a market capitalization of $362.67 billion, a PE ratio of 25.70, a P/E/G ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same period last year, the business earned $6.91 EPS. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 2.11%. UnitedHealth Group's dividend payout ratio (DPR) is presently 35.18%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.